Clinical Trials Update: Sept. 30, 2002
Chronic Pain Drugs Newly Approved by the FDA Hepsera Fluzone
Here are the latest clinical trials, courtesy of CenterWatch.
A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults with Severe Chronic Pain. Purpose of the study is to understand the effects of intrathecal ziconotide (an experimental pain medication) when the dose is slowly increased over a 3-week period. Sites throughout the USA.
Drugs Newly Approved by the FDA
Hepsera (adefovir dipivoxil)
For the treatment of chronic hepatitis B in adults with evidence of active viral replication; Gilead Sciences; Approved September 2002.
More InformationPlease see http://www.centerwatch.com/patient/drugs/dru797.html.
Preservative free, pediatric dose, influenza virus vaccine for the immunization of infants; Aventis Pasteur; Approved September 2002.
Copyright @#169;2002 Centerwatch. All rights reserved.